Merck touts new data for Keytruda combos in NSCLC at North American conference

Merck touts new data for Keytruda combos in NSCLC at North American conference

Submitted by admin on October 19, 2020 - 10:47am
Source: 
Endpoints
News Tags: 
Merck
clinical trials
Keytruda
non-small cell lung cancer
IASLC
Headline: 
Merck touts new data for Keytruda combos in NSCLC at North American conference
snippet: 

Merck marched out new data from two studies on Friday to back king Keytruda — the drug that made the Big Pharma $11.1 billion last year — in advanced non-small cell lung cancer (NSCLC).

Do Not Allow Advertisers to Use My Personal information